Risk factors affecting seizure recurrence in childhood epilepsy during short-term follow-up

Yasemin Baranoglu Kilinc1, Fatma Hancı2, Handan Ankaralı3

  • 1Department of Pediatrics, Faculty of Medicine, Training and Research Hospital, Bolu Abant Izzet Baysal University, Bolu, Turkey. yaseminbaranoglu@hotmail.com.

Insights

Seizure recurrence in pediatric epilepsy is higher in boys and those with abnormal neurological exams, global growth retardation, or comorbidities. Abnormal neuroimaging also increases recurrence risk. These factors are key for predicting outcomes.

Area of Science:

  • Neurology
  • Pediatrics
  • Epilepsy Research

Background:

  • Epilepsy is a common neurological disorder in children.
  • Understanding factors predicting seizure recurrence is crucial for effective management.
  • Pediatric epilepsy management requires identifying prognostic indicators.

Purpose of the Study:

  • To investigate factors influencing seizure recurrence in pediatric epilepsy patients.
  • To identify specific clinical and diagnostic markers associated with recurrent seizures.
  • To analyze risk factors for seizure recurrence in children treated with single antiseizure drugs.

Main Methods:

  • Retrospective analysis of 300 pediatric epilepsy patients (2015-2018).
  • Data collected from hospital records including medical history, clinical, and laboratory findings.
  • Multivariate binary logistic regression used to evaluate risk factors for seizure recurrence.

Main Results:

  • Higher seizure recurrence rates observed in boys compared to girls.
  • Abnormal neurological examinations, global growth retardation, and abnormal MRI findings were associated with increased recurrence.
  • Comorbidities like cerebral palsy and autism spectrum disorders significantly increased seizure recurrence risk.

Conclusions:

  • Abnormal neurological examination, neuroimaging, comorbidities, and global growth retardation are significant predictors of seizure recurrence in pediatric epilepsy.
  • These findings aid in risk stratification and personalized treatment strategies for children with epilepsy.
  • Early identification of these factors can improve long-term seizure control and patient outcomes.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
599
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
850
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
568
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
394
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
871